NDC 0143-9511

Etoposide

Etoposide

Etoposide is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by West-ward Pharmaceuticals Corp. The primary component is Etoposide.

Product ID0143-9511_5ea63f7d-fc26-4a51-a8aa-bdb385562e66
NDC0143-9511
Product TypeHuman Prescription Drug
Proprietary NameEtoposide
Generic NameEtoposide
Dosage FormInjection
Route of AdministrationINTRAVENOUS
Marketing Start Date1997-02-01
Marketing CategoryANDA / ANDA
Application NumberANDA074290
Labeler NameWest-Ward Pharmaceuticals Corp
Substance NameETOPOSIDE
Active Ingredient Strength20 mg/mL
Pharm ClassesTopoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 0143-9511-01

1 VIAL in 1 BOX, UNIT-DOSE (0143-9511-01) > 25 mL in 1 VIAL
Marketing Start Date2017-10-23
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0143-9511-01 [00143951101]

Etoposide INJECTION
Marketing CategoryANDA
Application NumberANDA074290
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2017-10-23

Drug Details

Active Ingredients

IngredientStrength
ETOPOSIDE20 mg/mL

OpenFDA Data

SPL SET ID:6dfedeff-a807-4405-a482-2f7109ad31c9
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 310248
  • Pharmacological Class

    • Topoisomerase Inhibitor [EPC]
    • Topoisomerase Inhibitors [MoA]

    NDC Crossover Matching brand name "Etoposide" or generic name "Etoposide"

    NDCBrand NameGeneric Name
    0143-9376EtoposideEtoposide
    0143-9510EtoposideEtoposide
    0143-9511EtoposideEtoposide
    0143-9512EtoposideEtoposide
    0378-3266Etoposideetoposide
    16729-114EtoposideEtoposide
    16729-262EtoposideEtoposide
    63323-104EtoposideETOPOSIDE
    68001-265EtoposideEtoposide
    0703-5653ToposarEtoposide
    0703-5656ToposarEtoposide
    0703-5657ToposarEtoposide

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.